Notably, in a preclinical model of lymphoma, Mpo mRNA was found to be expressed over 57‐fold higher in granulocytic MDSCs when compared with normal neutrophils isolated from tumour‐bearing or naive mice, respectively,24 suggesting that granulocytic MDSCs are a rich source of MPO in cancer. This evidence concerns the gene MPO and neoplasm.